Phase 3 clinical trials collectively referred to as the TRIUMPH programme are now underway internationally, evaluating retatrutide across broader populations including individuals with type 2 diabetes, obesity-related cardiovascular disease, and metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH)
Supports overall wellness By increasing NAD+ levels, you can help combat oxidative stress, reduce inflammation, and promote overall cellular health for long-term well-being
The serious pharmaceutical lane, metabolic, oncology, cardiovascular, rare disease
The hormone receptors that react to either peptide tend to be more reactive to sermorelin, and therefore, sermorelin tends to be more effective in raising HGH levels